Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Clinical trial NCT07489066 · RECRUITING

Trial details

NCT number: NCT07489066
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma Non-Small-Cell Lung Lung Cancer (NSCLC)Lung Neoplasms Carcinoma, Non-Small-Cell Lung (NSCLC)Lung Disease Non-Small Cell Lung Cancer Non-small Cell Lung Cancer, Non-squamous Non-small Cell Lung Cancer, Squamous

Start date: 2026-06-30
Primary completion: 2028-07-29
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.